about
Low autochtonous urban malaria in Antananarivo (Madagascar)Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in CambodiaChimpanzee malaria parasites related to Plasmodium ovale in AfricaA molecular marker of artemisinin-resistant Plasmodium falciparum malariaIn vitro activities of furoquinoline and acridone alkaloids against Plasmodium falciparumProlonged Plasmodium falciparum infection in immigrants, ParisNear-fatal multiple organ dysfunction syndrome induced by Plasmodium malariaeRapid dissemination of Plasmodium falciparum drug resistance despite strictly controlled antimalarial useSurveillance of travellers: an additional tool for tracking antimalarial drug resistance in endemic countriesHigh-throughput analysis of antimalarial susceptibility data by the WorldWide Antimalarial Resistance Network (WWARN) in vitro analysis and reporting tool.Combination of drug level measurement and parasite genotyping data for improved assessment of amodiaquine and sulfadoxine-pyrimethamine efficacies in treating Plasmodium falciparum malaria in Gabonese children.Performance of rapid diagnostic tests for imported malaria in clinical practice: results of a national multicenter studyPredictive factors of malaria in travelers to areas where malaria is endemic.Parasite virulence factors during falciparum malaria: rosetting, cytoadherence, and modulation of cytoadherence by cytokinesSevere imported falciparum malaria: a cohort study in 400 critically ill adults.Association of microsatellite variations of Plasmodium falciparum Na+/H+ exchanger (Pfnhe-1) gene with reduced in vitro susceptibility to quinine: lack of confirmation in clinical isolates from AfricaDecreased in vitro susceptibility of Plasmodium falciparum isolates to artesunate, mefloquine, chloroquine, and quinine in Cambodia from 2001 to 2007In vitro activities of benflumetol against 158 Senegalese isolates of Plasmodium falciparum in comparison with those of standard antimalarial drugs.Use of molecular beacons to detect an antifolate resistance-associated mutation in Plasmodium falciparumEmergence of resistance to atovaquone-proguanil in malaria parasites: insights from computational modeling and clinical case reportsIn vitro potentiation of antibiotic activities by a catecholate iron chelator against chloroquine-resistant Plasmodium falciparum.Rapid detection of a molecular marker for chloroquine-resistant falciparum malariaLack of association between putative transporter gene polymorphisms in Plasmodium falciparum and chloroquine resistance in imported malaria isolates from AfricaInvasion of Africa by a single pfcrt allele of South East Asian typeMolecular characterisation of airport malaria: four cases in France during summer 1999.Assessment of the drug susceptibility of Plasmodium falciparum clinical isolates from africa by using a Plasmodium lactate dehydrogenase immunodetection assay and an inhibitory maximum effect model for precise measurement of the 50-percent inhibitorThe mechanisms of resistance to antimalarial drugs in Plasmodium falciparum.In vitro activities of novel catecholate siderophores against Plasmodium falciparumPharmacokinetics of intramuscular amopyroquin in healthy subjects and determination of a therapeutic regimen for Plasmodium falciparum malaria.Potentiation of chloroquine activity against Plasmodium falciparum by the peroxidase-hydrogen peroxide system.Evaluation of the Clearview® Malaria pLDH Malaria Rapid Diagnostic Test in a non-endemic setting.Chloroquine uptake by Plasmodium falciparum-infected human erythrocytes during in vitro culture and its relationship to chloroquine resistance.In vitro activity of cycloguanil against African isolates of Plasmodium falciparum.Efficacy of intramuscular amopyroquin for treatment of Plasmodium falciparum malaria in the Gabon Republic.Efficacy of micronized halofantrine in semi-immune patients with acute uncomplicated falciparum malaria in CameroonIn vitro activities of chloroquine in combination with chlorpromazine or prochlorperazine against isolates of Plasmodium falciparum.Severe imported Plasmodium falciparum malaria, France, 1996-2003.Shelf life of predosed plates containing mefloquine, artemisinin, dihydroartemisinin, and artesunate as used for in vitro Plasmodium falciparum susceptibility assessmentChloroquine-resistant malaria in travelers returning from Haiti after 2010 earthquake.Evaluation of the intra- and inter-specific genetic variability of Plasmodium lactate dehydrogenase.
P50
Q21033513-2f7dcdb5-4056-15a9-f514-8e2c1848afc7Q21034146-a8ea7636-4b31-083f-fb93-d24736156fa5Q21562422-D2741B71-87BD-466C-9E5C-EFBF9230FFB6Q22061872-0CF7532C-7271-4CFF-99DF-4442676B60FAQ24679711-0627F766-0820-4DF8-A88F-ED0AC492AD60Q27487476-A136634A-8DD0-4CD0-9EFD-49F5D8821336Q27488427-60CC5F09-84AB-4A52-9C3C-D853965D534BQ28469104-AB027948-AB36-4EC0-8D51-8C7C587641A2Q28534753-E3E2AA44-2565-4A21-B145-6F3B8A511B81Q30619647-14E9EAEB-CDA2-4D74-B344-A4F6B2C1DF65Q30757681-4DE8B3FD-D20E-4D4D-A96F-09FC154035A1Q31140691-56213751-C07E-44A6-93F4-FD0A1ACE3559Q33343265-31EC7AEC-66F3-4A48-A04C-8C3558D70AAEQ33617104-5BE019B4-DBF0-49A9-BBDE-BC6CC129D964Q33719342-F14ADDBF-AB1B-4869-94F1-FC9BA13DB933Q33817484-4D7FC65C-D91D-49BD-8E9A-1E07FC0FFDDFQ33826378-D38D9930-7BF3-4C83-9082-DBB5D22CCA50Q33976132-34D25749-12AE-4EDE-B9EC-B679D5C1CE29Q33981071-EC15E33E-1609-4A40-BA1A-AFED5B79D5D4Q34058304-9C5D3871-92EE-497B-AE42-9DC3B8A6E8E8Q34104791-DCF49574-A119-4F01-A827-A2DD58BB896EQ34110766-2AFF48AD-0A40-452A-A442-FED26301352BQ34567489-42E67182-5CAD-41C1-9D38-5FA0951F6E8FQ34602866-BD438FE8-2D96-4A7E-B95E-A20E8BE89C92Q34737904-E6802384-DCFE-476F-ADCD-A7EFC6EF363EQ35091549-A8F5C4A4-C3CF-425B-B63E-01C712505431Q35095240-4D45F86A-CB6E-4D06-9E64-D374BAF748E0Q35126741-2CAE42FC-3034-41FE-9E0C-EC1E23088574Q35244822-3BAF8401-1EAC-47BF-B067-5C82583B8D47Q35277807-4D4FAEBD-391F-411F-96E2-7FDE7D9F12DBQ35390108-EC67D32F-8FB3-4F66-A6CE-D3BDCA578403Q35642579-CA75B20B-0EC8-412B-BA8E-3A884C222352Q35813108-95B5FBDC-DDD1-4BA7-96B6-BF266987CF1AQ35814071-E0E00755-6FAF-4A51-8137-0272DB40278EQ35819560-9FAC96BD-610B-44F4-A6DC-2CDA540D121DQ35843857-1EDF8727-7CB1-4558-938F-B093AF1BFA9BQ35876697-5918BC02-57D0-4622-887F-E02ECA637BD0Q35947492-4FAA4C8F-2A80-4F02-A40C-6CACE5C3C324Q36148058-FD597103-6E75-4E45-B6EA-8EEA4300A80BQ36372803-D956337F-E534-4195-AA56-3135E6B92659
P50
description
dokter
@id
hulumtues
@sq
médecin français
@fr
researcher
@en
հետազոտող
@hy
name
Jacques Le Bras
@ast
Jacques Le Bras
@br
Jacques Le Bras
@co
Jacques Le Bras
@da
Jacques Le Bras
@de
Jacques Le Bras
@en
Jacques Le Bras
@es
Jacques Le Bras
@fr
Jacques Le Bras
@id
Jacques Le Bras
@it
type
label
Jacques Le Bras
@ast
Jacques Le Bras
@br
Jacques Le Bras
@co
Jacques Le Bras
@da
Jacques Le Bras
@de
Jacques Le Bras
@en
Jacques Le Bras
@es
Jacques Le Bras
@fr
Jacques Le Bras
@id
Jacques Le Bras
@it
prefLabel
Jacques Le Bras
@ast
Jacques Le Bras
@br
Jacques Le Bras
@co
Jacques Le Bras
@da
Jacques Le Bras
@de
Jacques Le Bras
@en
Jacques Le Bras
@es
Jacques Le Bras
@fr
Jacques Le Bras
@id
Jacques Le Bras
@it